Literature DB >> 25855605

Epidemiology and pathophysiology of Takotsubo syndrome.

Yoshihiro J Akashi1, Holger M Nef2, Alexander R Lyon3.   

Abstract

Takotsubo syndrome is an acute cardiac syndrome first described in 1990 and characterized by transient left ventricular dysfunction affecting more than one coronary artery territory, often in a circumferential apical, mid-ventricular, or basal distribution. Several pathophysiological explanations have been proposed for this syndrome and its intriguing appearance, and awareness is growing that these explanations might not be mutually exclusive. The reversible apical myocardial dysfunction observed might result from more than one pathophysiological phenomenon. The pathophysiology of Takotsubo syndrome is complex and integrates neuroendocrine physiology, potentially involving the cognitive centres of the brain, and including the hypothalamic-pituitary-adrenal axis. Cardiovascular responses are caused by the sudden sympathetic activation and surge in concentrations of circulating catecholamines. The multiple morphological changes seen in the myocardium match those seen after catecholamine-induced cardiotoxicity. The acute prognosis and recurrence rate are now known to be worse than initially thought, and much still needs to be learned about the epidemiology and the underlying pathophysiology of this fascinating condition in order to improve diagnostic and treatment pathways.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25855605     DOI: 10.1038/nrcardio.2015.39

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  114 in total

1.  Simple and accurate electrocardiographic criteria to differentiate takotsubo cardiomyopathy from anterior acute myocardial infarction.

Authors:  Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Satoshi Morita; Jun Okuda; Noriaki Iwahashi; Kengo Tsukahara; Tatsuya Nakachi; Masayoshi Kiyokuni; Toshiyuki Ishikawa; Satoshi Umemura; Kazuo Kimura
Journal:  J Am Coll Cardiol       Date:  2010-06-01       Impact factor: 24.094

2.  Natural history of tako-tsubo cardiomyopathy.

Authors:  Guido Parodi; Benedetta Bellandi; Stefano Del Pace; Alessandro Barchielli; Linda Zampini; Silvia Velluzzi; Nazario Carrabba; Gian Franco Gensini; David Antoniucci
Journal:  Chest       Date:  2010-09-30       Impact factor: 9.410

3.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

4.  Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy.

Authors:  Scott W Sharkey; Denise C Windenburg; John R Lesser; Martin S Maron; Robert G Hauser; Jennifer N Lesser; Tammy S Haas; James S Hodges; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

5.  The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase.

Authors:  A Chesley; M S Lundberg; T Asai; R P Xiao; S Ohtani; E G Lakatta; M T Crow
Journal:  Circ Res       Date:  2000-12-08       Impact factor: 17.367

6.  Chronic estrogen supplementation following ovariectomy improves the emotional stress-induced cardiovascular responses by indirect action on the nervous system and by direct action on the heart.

Authors:  Takashi Ueyama; Fuminobu Ishikura; Akiko Matsuda; Toshihiko Asanuma; Kazuki Ueda; Masao Ichinose; Ken Kasamatsu; Takuzo Hano; Takashi Akasaka; Yoshihiro Tsuruo; Keiko Morimoto; Shintaro Beppu
Journal:  Circ J       Date:  2007-04       Impact factor: 2.993

7.  Stress-induced cardiomyopathy in Sweden: evidence for different ethnic predisposition and altered cardio-circulatory status.

Authors:  Tomas Schultz; Yangzhen Shao; Björn Redfors; Yrsa Bergmann Sverrisdóttir; Truls Råmunddal; Per Albertsson; Göran Matejka; Elmir Omerovic
Journal:  Cardiology       Date:  2012-07-27       Impact factor: 1.869

8.  Left ventricular apical ballooning syndrome: prevalence, clinical characteristics and pathogenetic mechanisms in a European population.

Authors:  Mario Previtali; Alessandra Repetto; Stefania Panigada; Rita Camporotondo; Luigi Tavazzi
Journal:  Int J Cardiol       Date:  2008-05-27       Impact factor: 4.164

9.  Estrogen reduces cardiac injury and expression of beta1-adrenoceptor upon ischemic insult in the rat heart.

Authors:  Kenneth W L Kam; Jian Song Qi; Mai Chen; Tak Ming Wong
Journal:  J Pharmacol Exp Ther       Date:  2004-01-12       Impact factor: 4.030

10.  A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction.

Authors:  Milosz Jaguszewski; Julia Osipova; Jelena-Rima Ghadri; Lars Christian Napp; Christian Widera; Jennifer Franke; Marcin Fijalkowski; Radoslaw Nowak; Marta Fijalkowska; Ingo Volkmann; Hugo A Katus; Kai C Wollert; Johann Bauersachs; Paul Erne; Thomas F Lüscher; Thomas Thum; Christian Templin
Journal:  Eur Heart J       Date:  2013-09-17       Impact factor: 29.983

View more
  79 in total

Review 1.  The role of multimodality imaging in takotsubo cardiomyopathy.

Authors:  Osamu Manabe; Masanao Naya; Noriko Oyama-Manabe; Kazuhiro Koyanagawa; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2018-06-01       Impact factor: 5.952

2.  Autonomic nervous system and a 'vascular phase' in Takotsubo syndrome pathogenesis.

Authors:  John E Madias
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

3.  Takotsubo cardiomyopathy and microcirculatory dysfunction.

Authors:  Nauman Khalid; Lovely Chhabra
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

Review 4.  Takotsubo syndrome: an overview of pathophysiology, diagnosis and treatment with emphasis on cancer patients.

Authors:  Isabela Bispo Santos da Silva Costa; Clara Salles Figueiredo; Silvia Moulin Ribeiro Fonseca; Cristina Salvadori Bittar; Carolina Maria Domingues de Carvalho Silva; Stéphanie Itala Rizk; Roberto Kalil Filho; Ludhmila Abrahão Hajjar
Journal:  Heart Fail Rev       Date:  2019-11       Impact factor: 4.214

Review 5.  Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review.

Authors:  Horacio Medina de Chazal; Marco Giuseppe Del Buono; Lori Keyser-Marcus; Liangsuo Ma; F Gerard Moeller; Daniel Berrocal; Antonio Abbate
Journal:  J Am Coll Cardiol       Date:  2018-10-16       Impact factor: 24.094

6.  Takotsubo cardiomyopathy associated with Kounis syndrome: A clinical case of the "ATAK complex".

Authors:  Davide Margonato; Raffaele Abete; Gabriella Di Giovine; Pietro Delfino; Massimiliano Grillo; Simone Mazzetti; Daniele Poggio; Jessica Rossi; Toufic Khouri; Andrea Mortara
Journal:  J Cardiol Cases       Date:  2019-05-01

Review 7.  Role of echocardiography for takotsubo cardiomyopathy: clinical and prognostic implications.

Authors:  Masaki Izumo; Yoshihiro J Akashi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

8.  Image Diagnosis: Takotsubo Cardiomyopathy Mimicking an Acute ST Elevation Myocardial Infarction in the Setting of Anti-Depressant Therapy Withdrawal.

Authors:  Suha Na Javeed; Seema Pursnani
Journal:  Perm J       Date:  2020-04-03

Review 9.  Takotsubo syndrome: Advances in the understanding and management of an enigmatic stress cardiomyopathy.

Authors:  Hernán David Mejía-Rentería; Iván J Núñez-Gil
Journal:  World J Cardiol       Date:  2016-07-26

10.  Trends in Short- and Long-Term Outcomes for Takotsubo Cardiomyopathy Among Medicare Fee-for-Service Beneficiaries, 2007 to 2012.

Authors:  Karthik Murugiah; Yun Wang; Nihar R Desai; Erica S Spatz; Sudhakar V Nuti; Rachel P Dreyer; Harlan M Krumholz
Journal:  JACC Heart Fail       Date:  2015-12-30       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.